Onyx Biotec Limited (NSE:ONYX)

India flag India · Delayed Price · Currency is INR
50.30
-2.35 (-4.46%)
At close: May 20, 2025
-6.94%
Market Cap 912.04M
Revenue (ttm) 609.58M
Net Income (ttm) 44.17M
Shares Out 18.13M
EPS (ttm) 3.47
PE Ratio 14.48
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,000
Average Volume 40,300
Open 51.95
Previous Close 52.65
Day's Range 48.05 - 51.95
52-Week Range 48.90 - 97.45
Beta n/a
RSI 43.95
Earnings Date Aug 1, 2025

About Onyx Biotec

Onyx Biotec Limited develops, manufactures, and distributes generic pharmaceutical products in India and internationally. The company offers sterile water for injections; and acts as a pharmaceutical contract manufacturer for a range of dry powder injections and dry powder syrups cephalosporins. It also exports its products. The company was incorporated in 2005 and is based in Chandigarh, India. [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol ONYX
Full Company Profile

Financial Performance

In 2023, Onyx Biotec's revenue was 537.49 million, an increase of 36.10% compared to the previous year's 394.92 million. Earnings were 30.32 million, an increase of 64.35%.

Financial Statements

News

There is no news available yet.